Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors

Clinical Nephrology

Volumn 47, Issue 4, 1997, Pages 243-247

  Djordjevic V B ^a,c   Pavlovic D ^a   Pejovic M ^b   Cvetkovic T ^a   Lecic N ^b   Deljanin Ilic M ^a  

^a Institute of Biochemistry Faculty of Medicine

^b Department of Medical Biochemistry Clinical Center

^c Medicinski Fakultet

Author keywords

ACE inhibitors; Catalase; Glutathione; Glutathione S; Lipid peroxides; Transferase

Indexed keywords

ANTIOXIDANT; CAPTOPRIL; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ERYTHROCYTE ENZYME; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; OXIDATIVE STRESS;

EID: 0030896590     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Adachi Y, Horii K, Takahashi Y, Tanihata M, Ohba Y, Yamamoto T 1980 Serum glutathione S-transferase activity in liver diseases. Clin Chim Acta 106: 243-255
2. Andreeva IL, Kozenjakin AL, Kiskin AA 1988 A modification of method for the determination of lipid peroxides by the tiobarbituric acid test. Lab Delo 11: 41-43
3. Ball SG 1992 Cardioprotection and ACE inhibitors. Clin Physiol Biochem 9: 98-104
4. Becker BF, Reiholz N, Leipert B, Raschke P, Gerlach E 1991 Sind Radikalenfänger-Eigenschaften von ACE-Inhibitoren mit Sulfhydrylgruppen bei therapeutisch wirksamen Konzentrationen von quantitativer Bedeutung. Klin Wochenschr 69 (Suppl XXIV): 6-9
5. Beutler E 1982 Catalase. In: Beutler E (ed). Cell Metabolism Manual of Biochemical Method. Grune and Stratton, New York, pp 105-106
6. Beutler E, Duron O, Kelly MB 1963 Improved method for the determination of blood glutathione. J Lab Clin Med 61: 882-888
7. Clapperton M, McMurray J, Simpson K, Fisher AC, Dargie HJ 1992 Captopril inhibits human neutrophil chemotaxis. Eur Heart J 13 (Suppl): 356 (Abstract)
8. De Graef PA, Van Gilst WH, Bel K, de Langen CD, Kingma JH, Wesseling H 1987 Concentration dependent protection by captopril against myocardial damage after ischemia-reperfusion injury in a closed chest pig model. J Cardiovasc Pharmac 9 (Suppl 2): S37-S42
9. Di Pasquale P, Paterna S, Cannizzaro S, Albano V, Valdes L, Licata G, Barone G 1992 Captopril and glutathione before thrombolysis in acute myocardial infarction: a pilot study. Drugs Exp Clin Res 18: 401-406
10. Habig HW, Pabst JM, Jakoby BW 1874 Glutathione S-transferases. J Biol Chem249: 7130-7139
11. Jenkins AC, Dreslinski GR, Tadros SS, Groel JT, Fand R, Horczeg GA 1985 Captopril in hypertension: seven years later. J Cardiovasc Pharmacol 7 (Suppl 1): S96-S101
12. Kilgore KS, Homeister JW, Satoh PS, Lucches BR 1994 Sulphydryl compounds, captopril and MPG inhibit complement-mediated myocardial injury. Am J Physiol 266: H28-H35
13. Koracevic G, Pavlović D, Djordjević V 1994 Is captopril scavenger of free radicals in myocardium? Acta Biol Med Exp 19: 39-41
14. Koroljuk MA, Ivanova LI, Majorova IG, Tokarev VE 1988 A method for the determination of catalase activity. Lab Delo 1: 16-18
15. Kondo T, Taniguchi N, Kawakami Y 1984 Significance of glutathione S-conjugate for glutathione metabolism in human erythrocytes. Eur J Biochem 145: 131-136
16. Kukreja RC, Kontos HA, Hess ML 1990 Captopril and enalaprilat do not scavenge the Superoxide anion. Am J Cardiol 65: 241-271
17. Mak IT, Freedman AM, Dickens BF, Weglick WB 1990 Protective effects of sulphydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol 40: 2169-2175
18. Meister A, Anderson ME 1983 Glutathione. Ann Rev Biochem 52: 711-760
19. Marre M, Hallab M, Billiard A, Le Jeune JJ, Bled F, Girault A, Fressinaud P 1989 Dissociated effects of an angiotensin converting enzyme inhibitor on systemic blood pressure and renal haemodynamics in incipient diabetic nephropathy. Diabetologica 32: 514A
20. Martin MFR, McKenna F, Bird HA, Surrall KE, Dixon JS, Wright V 1984 Captopril: a new treatment for rheumatoid arthritis? Lancet i: 1325-1327
21. McMurray J, Chopra M, Smith WE, Dargie HJ 1992 Antioxidant actions of SH containing angiotensin converting enzyme inhibitors. Eur Heart J 13 (Suppl): 356 (Abstract)
22. Mira ML, Silva MM, Queiroz MJ, Manso CF 1993 Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Radic Res Commun 79: 173-181
23. Morelli E, Loon N, Meyer T, Peters W, Meyers B 1990 Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39: 76-82
24. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G 1993 Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 6: 36-43
25. Ritz E 1992 ACE inhibition and renal protection. Clin Physiol Biochem 9: 94-97
26. Tkaczewski W, Kedziora J, Buczynski A, Ryniec A, Blaszczvk J, Dziekanski S 1989 Blood platelets: aggregation, malonyl dialdehyde concentration and SOD-1 activity in patients with coronary heart disease after captopril administration. MacGregor GA, Sever PS (eds). Current advances in ACE inhibition. London, 191-193
27. Tang ZH, Chen TZ 1993 Peroxidation injury of endothelial cells and atherosclerosis development. Chung-hua-Ping-Li-Hsueh-TsaChin 22: 46-48
28. Van Gilst WH, de Graeff PA, Kingma JH, Wesseling H, de Langen CD 1984 Captopril reduces purine loss and reperfusion arrhythmia in the rat heart after coronary artery occlusion. Eur J Pharmacol 700: 113-117
29. Van Gilst WH, de Graeff PA, Wesseling H, de Langen CD 1986 Reduction of reperfusion arrhythmia in the ischemic isolated rat heart by ACE I. J Cardiovasc Pharmacol 8: 722-728
30. Vidt DG 1984 A controlled multiclinic study to compare the antihypertensive effects of MK 421, hydrochlorothiazide and MK 421 combined with hydrochlorothiazide in patients with mild tomoderate essential hypertension. J Hypertens 2 (Suppl 2): 81-88
31. Wen Y, Qian XX, Jia GL, Gao SB, Jin YF, Han DY, He SF 1993 Correlation of serum lipids, lipoproteins, lipid peroxidase products and metals with coronary heart disease. Chin Med J Engl 106. 167-170
32. Wakabayashi I, Yoshimoto S, Masui H, Sakamoto K, Kinoshita H 1992 A study of factors affecting the concentration of serum lipid peroxide in the elderly inhabitants in a rural area. NipponRonen-Igakkai-Zasshi 29: 783-789